Home

ABOUT US

Our mission is to transform ADC cancer therapy, providing renewed hope to patients worldwide. Grounded in a profound comprehension of chemistry and drug delivery, our ultimate objective is to pioneer groundbreaking ADC therapeutics capable of addressing and treating a spectrum of cancers. We are committed to pushing the boundaries of the realm of cancer treatment, working tirelessly to bring about a future where innovative solutions offer life-changing possibilities for all patients.

Xiling Lab, a pioneering high-tech company based in China at the forefront of ADC therapeutics for cancer treatment. Leveraging our cutting-edge XL-XDC^® technology platform, we specialize in developing innovative solutions to target various cancers.